Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Aequus Pharmaceuticals

Aequus Pharmaceuticals?uq=2zON1W4M
2013 FOUNDED
PUBLIC STATUS
1-10 EMPLOYEES
AQS STOCK SYMBOL
2 INVESTMENTS
$0.13 SHARE PRICE (As of Tuesday Closing)
Description

Provider of drug delivery services and other consumer products. The company's drug delivery business focuses on enhancing delivery methods for approved drugs and select consumer products that are limited by non-compliance, high-frequency dosing, first-pass metabolism side-effects, painful injections or where the therapeutic profile can be improved by making a long-acting alternative available.

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Stock Exchange
TSX
Primary Office
  • 2820-200 Granville Street
  • Vancouver, British Columbia V6C 1S4
  • Canada

+1 (604) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Aequus Pharmaceuticals’s full profile, request a free trial.

Aequus Pharmaceuticals Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.12 - $0.34 $10.5M $0.13 -$0.03 104K 80.4M

Aequus Pharmaceuticals Financials Summary

In Thousands,
USD
TTM
30-Jun-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
FY 2015
31-Dec-2015
Enterprise Value 10,021 14,694 8,773 14,592
Revenue 1,112 878 529 0
EBITDA (2,285) (2,856) (3,540) (3,863)
Net Income (2,421) (2,991) (3,630) (3,931)
Total Assets 1,416 2,125 1,495 1,751
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Aequus Pharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Aequus Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Aequus Pharmaceuticals Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000-00000 000 11-Jan-2018 00000 0000000 Biotechnology 0000000 000000
TeOra Health 28-Jul-2015 Merger/Acquisition 00.000 Other Commercial Services 0000000 000000
To view this company’s complete investment and acquisition history, request access »

Aequus Pharmaceuticals Executive Team (7)

Name Title Board
Seat
Contact
Info
Donald McAfee Ph.D Chief Scientific Officer
Ian Ball Chief Commercial Officer
Douglas Janzen Chief Executive Officer & Chairman
Ann Fehr Chief Financial Officer
Anne Stevens Chief Operating Officer & Director

2 Former Executives

You’re viewing 5 of 7 executives. Get the full list »

Aequus Pharmaceuticals Board Members (2)

Name Representing Role Since Contact
Info
0000000 000000 Self Chief Executive Officer & Chairman 000 0000

1 Former Board Member

You’re viewing 1 of 2 board members. Get the full list »